Evidence for Clinical Safety, Efficacy, and Parent and Physician Perceptions of Levocetirizine for the Treatment of Children with Allergic Disease
Explore this paper's citation graph
Summary
Levocetirizine is the only H1-antihistamine launched in the 21st century shown to lack clinically relevant adverse effects on physical and psychomotor development or routine laboratory tests over a long-term period of 18 months in 1- to 3-year-old children predisposed to development of allergic disease.
- Type
- article
- Published
- 2011-02-22
- Cited by
- 37
- References
- 77
- OpenAlex
- https://openalex.org/W21346367
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:26421632
Keywords
Economics, Political science
References
- Internal and External Environmental Influences in Allergic Diseases
- Anti-histamines for prolonged non-specific cough in children.
- Allergic rhinitis in children
- High prevalence of asthma and allergic diseases in children aged 6 to [corrected] 7 years from the Canary Islands. [corrected].
- The diagnosis and management of rhinitis: an updated practice parameter.
- Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study
- Pediatric allergic rhinitis: physical and mental complications.
- Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years.
- Relevance of H1-receptor occupancy to H1-antihistamine dosing in children.
- Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium
- A survey of the burden of allergic rhinitis in the USA
- Frequency of Fungi in Homes of Pediatric Allergy Patients
- Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile.
- A survey of the burden of allergic rhinitis in Europe.
- Congress, the FDA, and the fair development of new medications for children.
- Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial.
- Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.
- Over the counter but no longer under the radar--pediatric cough and cold medications.
- Use of Sleep Medications in Hospitalized Pediatric Patients
- Risk of first‐generation H1‐antihistamines: a GA2LEN position paper
Cited by
- Statistical study on the incidence of allergic diseases treated with desloratadine and levocetirizine at "Atopia" Allergology Medical Center, Iaşi, Romania.
- Urticarias en el niño
- Update on Antihistamine Treatment for Chronic Urticaria in Children
- Off-label prescribing for allergic diseases in children
- Comparison of levocetirizine pharmacokinetics after single doses of levocetirizine oral solution and cetirizine dry syrup in healthy Japanese male subjects
- Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial
- Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study Design
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
- EAACI/GA2LEN/EDF/WAO-Leitlinie für die Definition, Klassifikation, Diagnose und das Management der Urtikaria — konsentierte, deutschsprachige Übersetzung
- Prescription Profile and Clinical Outcomes in Patients with Allergic Rhinitis Treated with Oral Antihistamines or Nasal Corticosteroids
- The safety and tolerability profile of bilastine for chronic urticaria in children
- Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, diagnostyki i leczenia pokrzywki
- Efficacy and tolerability of the updosing of second‐generation non‐sedating H1 antihistamines in children with chronic spontaneous urticaria
- Effectiveness of antihistamines for itch and sleep disturbance in atopic dermatitis: a retrospective cohort study
- The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
- Non-sedative Antihistamines: Assessment of Efficacy Based on Total Nasal Symptom Score in Patient with Allergic Rhinitis.
- Drugs repurposing: An approach to identify new hits against anticancer drug target TFIIH subunit p8.
- Childhood urticaria
- Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review
- Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Levocetirizine dihydrochloride.
Related papers
No related papers recorded.